Alzheimer's disease (AD) is a progressive neurodegenerative disorder characterized by cognitive decline and substantial brain atrophy. Early and accurate prediction of disease progression and staging is crucial for timely intervention and effective t... read more
Neuroscience and biobehavioral reviews
Apr 22, 2026
Quantifying behavior in animal models is essential for understanding neurological disorders, yet traditional scoring methods often fail to capture the complexity and heterogeneity of motor dysfunction. Recent advances in artificial intelligence (AI) ... read more
Wearing-off (WO) is a common motor complication in Parkinson's disease (PD), characterized by the re-emergence of symptoms before the next dose of dopaminergic medication and still lacking objective, bedside-available neurophysiological biomarkers. I... read more
OBJECTIVES: Clinical document metadata, such as document type, structure, author role, medical specialty, and encounter setting, is essential for accurate interpretation of information captured in clinical documents. However, vast documentation heter... read more
This study presents a novel data selection framework for enhancing the training efficiency of large language models (LLMs) in biomedical natural language processing (NLP) tasks. We focus on critical tasks sourced from the biomedical dataset, encompas... read more
Due to the ability for high-resolution molecular imaging and chemical analysis with spatial resolution, time-of-flight secondary ion mass spectrometry (TOF-SIMS) is an extremely powerful surface analysis technique that is commonly used for chemical a... read more
Vibrio vulnificus is a highly lethal zoonotic pathogen associated with seafood consumption and aquaculture environments, demanding rapid and reliable on-site molecular diagnostics. Here, we report an intelligent biosensing platform utilizing a deep l... read more
The short metabolic half-life of conventional tobacco biomarkers often limits their ability to reflect cumulative toxicological damage, which may complicate risk stratification for urothelial carcinoma (UC). This study explored an explainable artific... read more
The drug development for central nervous system (CNS) disorders, particularly neurodegenerative diseases, such as Alzheimer's disease, Parkinson's disease, and Huntington's disease, faces formidable challenges. While proteolysis-targeting chimeras (P... read more
BACKGROUND: Clinicians are the interface between artificial intelligence (AI) applications and patient care. To maximize benefits and minimize risks of AI, clinicians must be "AI-ready"-that is, willing and able to understand, evaluate, and appropria... read more
Don't Miss the Future of Medicine
Join thousands of healthcare professionals staying informed about the latest AI breakthroughs in medicine. Get curated insights delivered to your inbox.